Analytica China exhibition in Shanghai.

As China’s first listed IVD company, KHB has been a pioneer in liver disease diagnostics since the 1990s. We developed China’s first ELISA reagent for Hepatitis B and C, playing a key role in advancing liver disease prevention and control. Early Detection is Key to Preventing Liver Damage Hepatitis, a viral infection affecting millions globally, can lead to severe liver...

We’re thrilled to be here at Booth No. 7-C0202, Hall 7, showcasing our latest innovations across #immunology, #biochemistry, #molecular diagnostics, #POCT, and mass spectrometry. Featured Highlights: ✅ Biochemical Immune Streamline | KHB Mini Las ✅ Mass Spectrometry Series | KHB Nova 9600 Automated Sample Processing System and more ✅ Fully Automated Molecular Integration...

March marks World TB Day, a time to raise awareness about tuberculosis and its diagnosis. In honor of this, PCR.NEWS is hosting a scientific and practical webinar on the latest advancements in molecular diagnostics and epidemiology of tuberculosis and mycobacteriosis. Tianlong is honored to be invited to speak at this event! Topic: Tianlong's Integrated TB Solution: ...